EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Soluble Urokinase Plasminogen Activator Receptor: A Promising Biomarker for Mortality Prediction Among Critical ED Patients

Piotr Wozniak iD, Mariusz Sieminski iD, Jan Pyrzowski, Rafael Petrosjan, Jakub Głogowski-Kulasza, Jakub Leszczyński-Czeczatka

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26041609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Piotr Wozniak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Medical University of Gdansk, 80-210 Gdansk, Poland. Hauptthemen laut MEDLINE: Receptors, Urokinase Plasminogen Activator, Biomarkers, Critical Illness, Emergency Service, Hospital. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients admitted to the emergency department (ED) are a highly diverse group in terms of the risk of death. In overcrowded EDs, it becomes crucial to quickly and reliably estimate the risk of death or significant health deterioration. For this purpose, the concentration of soluble urokinase plasminogen activator receptor (suPAR) in plasma has been studied in recent years in various patient populations. In the present study, we tested the hypothesis that measuring suPAR upon the ED admission of critically ill patients can identify those at the highest mortality risk. To verify this hypothesis, we analyzed the relationship between suPAR plasma concentration, other biochemical parameters, and Early Warning Scores (EWSs) on admission and survival to hospital discharge. The study group consisted of 61 ED patients with priority 1 in the Manchester Triage System (MTS), excluding patients with illness caused by environmental factors. Positive correlations between suPAR and inflammatory parameters such as CRP and PCT, as well as the warning scales MEWS, MEDS, and qSOFA, were confirmed. Plasma suPAR concentration on admission was found to be a promising predictor of in-hospital mortality. The study indicated the potential prognostic value of suPAR as the mortality risk predictor for a specific population of critically ill ED patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Urokinase Plasminogen ActivatorBiomarkersCritical IllnessEmergency Service, HospitalHospital MortalityHumansMaleFemaleMiddle AgedAgedPrognosisAdultTriageAged, 80 and over

Stichwörter der Autor:innen

emergency departmentin-hospital mortalityinflammatory markersmortality risksuPAR

Substanzen

Receptors, Urokinase Plasminogen ActivatorBiomarkers

Autor:innen und Institutionen

  • Department of Emergency Medicine, Medical University of Gdansk, 80-210 Gdansk, Poland.

ORCID-Profile: Piotr Wozniak, Mariusz Sieminski

Zitieren

APA

Wozniak, P., Sieminski, M., Pyrzowski, J., Petrosjan, R., Głogowski-Kulasza, J., & Leszczyński-Czeczatka, J. (2025). Soluble Urokinase Plasminogen Activator Receptor: A Promising Biomarker for Mortality Prediction Among Critical ED Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041609

Vancouver

Wozniak P, Sieminski M, Pyrzowski J, Petrosjan R, Głogowski-Kulasza J, Leszczyński-Czeczatka J. Soluble Urokinase Plasminogen Activator Receptor: A Promising Biomarker for Mortality Prediction Among Critical ED Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041609

BibTeX
@article{Wozniak2025,
  author = {Wozniak, Piotr and Sieminski, Mariusz and Pyrzowski, Jan and Petrosjan, Rafael and Głogowski-Kulasza, Jakub and Leszczyński-Czeczatka, Jakub},
  title = {Soluble Urokinase Plasminogen Activator Receptor: A Promising Biomarker for Mortality Prediction Among Critical ED Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26041609}
}
Kostenlos starten →